Metoprolol

Revision as of 16:12, 26 March 2014 by Gerald Chi (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Metoprolol Succinate

Metoprolol Succinate/Hydrochlorothiazide

Metoprolol Tartrate

Metoprolol Tartrate/Arginine

Metoprolol Tartrate/Hydrochlorothiazide

Overview

Metoprolol is a competitive, β1-selective (cardioselective) blocker used in treatment of angina pectoris, hypertension, arrhythmia, and migraine. Common adverse reactions include bradyarrhythmia, heart block, heart failure, hypotension, pruritus, rash, constipation, diarrhea, indigestion, nausea, dizziness, fatigue, headache, depression, dyspnea, and wheezing.

The active substance metoprolol is employed either as metoprolol succinate or as metoprolol tartrate. The tartrate is an immediate-release and the succinate is an extended-release formulation.

Category

Anti-anginal, antiarrhythmic, beta-adrenergic blocker